Skip to content
Home > Staff and Recruitment > Staff Resources and Support > Research and Innovation > R&I Management Office

R&I Management Office

************************ Many of the R&I team are working remote from our core offices – please use email or Teams as primary method of contact *************************

Research affects us all; many of the technologies and therapies that we associate with the delivery of a modern health service have their origin in research. Therefore, research is essential to developing the evidence base for the successful promotion and protection of health and well-being and to modern and effective health and social services.

By its very nature, research can involve an element of risk, both in terms of return on investment and sometimes for the safety and well-being of research participants. Therefore proper governance of research is essential to ensure that the public can have confidence in, and benefit from, quality research in health and community care. Glasgow has a long history of groundbreaking research that has resulted in real benefits to patients around the globe.

The team at R&I are keen to foster this spirit and offer extensive support to new and experienced researchers

Research & Innovation

NHS Greater Glasgow & Clyde

Ward 11, Dykebar Hospital

Grahamston Road

Paisley

PA2 7DE

About Us

Who Are We?

‘A multidisciplinary team promoting, co-ordinating and facilitating all aspects of high quality research within NHS Greater Glasgow & Clyde’

The R&I Management office acts as a catalyst for discovery and innovation within NHSGGC. We have a ‘can-do’ attitude, striving to support both experienced and new researchers in the design and execution of high quality research studies and ensure compliance to all regulatory requirements.

As the busiest R&I office in Scotland, we received in excess of 620 new research applications in 2021 and have approximately 1000 studies ongoing at any one time. To ensure consistency of contact, and to help develop an in-depth understanding of therapy area-specific research projects, the NHSGGC R&I Management office has adopted a ‘portfolio-team’ structure. The portfolio teams form the functional core of R&I and are comprised of Research Co-ordinators, Research Facilitators, Research Administrators and clerical support staff.

The teams work together to support and encourage investigators and manage the R&I process from concept to approval and final report. Specifically, Research Co-ordinators and Facilitators act as an ‘advocate’ for the researcher and balance the administrative burden associated with clinical research against regulatory requirements.

Where to Find Us?

The R&I Management office is situated at Dykebar Hospital, Paisley.

Our postal address is:

Research & Innovation

NHS Greater Glasgow & Clyde

Ward 11, Dykebar Hospital

Grahamston Road

Paisley

PA2 7DE

Contact Us

Portfolio 1

Dr George Bakirtzis Commercial Research Coordinator 0141 314 0225  Randdsystems.PF1@ggc.scot.nhs.uk 

Dr Ross Collins Research Facilitator 0141 314 0221 Randdsystems.PF1@ggc.scot.nhs.uk

Mrs Carolyn Malloch Research Administrator 0141 314 0229

Portfolio 2 

Mr Ross Nicol Commercial Research Coordinator 0141 314 0221

Mrs Karen Puglisevich Chase Research Facilitator 0141 314 0222

Ms Oumaima Abakar Ismail Research Administrator (NHS GG&C Hosted & Commercial studies) 0141 314 0217

Portfolio 3

Mrs Ruth Pink Commercial Research Coordinator 0141 314 0217

Ms Natalie Phillips Research Administrator 0141 314 0216

Sponsor Portfolio

Ms Joanne McGarry Academic Research Co-ordinator 0141 314 4001

Mrs Barbara Ross Academic Research Co-ordinator 0141 314 4011

Dr Maureen Travers Academic Research Coordinator 0141 314 4012

Dr Pamela Sandu Academic Research Co-ordinator 0141 314 4414

Ms Brittany Graham Senior Research Administrator 0141 314 4011

Ms Hannah Greenwood Senior Research Administrator 0141 314 4011

R&I Proportionate Review Team

Ms Rebecca Jardine Research Facilitator 0141 314 4172

Mrs Kirsty Theron Senior Research Administrator 0141 314 4001

Ms Kirstie Farquhar Senior Research Administrator   0141 314 4001

Audit & Monitoring

Mrs Eileen McCafferty Audit Facilitator 0141 314 4429 

Dr Sheila McGowan Lead Clinical Trials Monitor 0141 314 4414 

Emma Moody Clinical Trials Monitor 0141 314 4485

Dr Margaret Fegen Clinical Trials Monitor 0141 314 4414

Position Vacant Clinical Trials Monitor

Emma Whitelaw Governance Research Facilitator 0141 314 4429

Paul Gribbon Quality Assurance Manager

Research Pharmacy

Dr Samantha Carmichael Lead Pharmacist 0141 314 0232

Dr. Elizabeth Douglas Clinical Trials Pharmacist 0141 314 4073

Ms Paula Morrison Senior Pharmacist Clinical Trials – Oncology 0141 314 4019

Mrs. Eliza Valentine Senior Pharmacy Technician 0141 314 4018

Mrs. Pamela Surtees Lead Pharmacy Technician Clinical Trials 0141 314 4083

Ms Angela Carruth Pharmacy Facilitator 0141 314 4081 / 0141 211 3319

Pharmacovigilance Office

Dr Marc Jones Trial Safety Manager 0141 314 4434

Admin Pharmacovigilance Administrator     

R&I Director

Prof Julie Brittenden R&I Director 0141 314 0327

R&I Managers

Ms Chloe Cowan Senior R&I Manager 0141 314 0233

Dr Caroline Watson Research Governance Manager 07899 595 682

Dr Melissa Robert R&I Systems Manager 0141 314 4125

Dr Samantha Carmichael Lead Pharmacist 0141 314 0232

Ms Michelle McDermott Management Secretary 0141 314 0327

R&I Information Officer

Mr Radek Penar Information Officer 0141 314 0226

NRS Performance Manager

Mr Graeme Piper NRS Performance Manager 0141 314 0230

Ms Islay Morrison Research Administrator 0141 314 0230

R&I Approval Process

What is R&I approval?

R&I approval provides permission for a study to commence within NHS Greater Glasgow & Clyde (NHSGGC) and is required for all research studies involving NHS patients, their tissues or information, or studies involving NHS staff participating by virtue of their profession. 

R&I approval ensures that the legal obligations of the board, outlined in the Research Governance Framework (2nd edition, 2006), are met and is issued following a formal review of the project by designated staff. In addition, R&I approval provides insurance/indemnity for research projects under the Clinical Negligence and Other Risks Indemnity Scheme (CNORIS) and is a condition of ethical favourable opinion. The Research Governance Framework can be found here

The R&I approval process ensures:

  • An appropriate study sponsor is identified
  • The scientific quality of the proposal (as required)
  • That there is a favourable ethical opinion from an appropriate REC
  • Appropriate regulatory authorisations are in place
  • Appropriate risk/benefit analysis
  • Provisions for appropriate insurance/indemnity
  • The financial and resource implications of the study are assessed
  • Appropriate trial registration
  • All researchers have substantive or honorary NHS GG&C contracts
  • All researchers are adequately qualified
  • Support department approval
  • Formal agreements or contracts with external bodies meet the requirements of the Board.

All research conducted within the NHS must have R&I Management Approval

Who provides R&I approval?

Commercial

Commercial research is defined as research that is funded and sponsored by a commercial organisation.  A study is defined as industry sponsored and funded if a commercial company has developed the study protocol and is fully funding the additional costs of hosting the trial within the NHS. These trials must be supported by a Clinical Trials Agreement and appropriate indemnification.  

The Co-ordinators for Commercial research in NHSGGC are:

Click here for further information on Commercial Research, including details on the specific therapy areas covered by each Portfolio Team

Non Commercial NHSGGC Sponsored 

A ‘sponsor’ is defined as – an individual or organisation that takes on responsibility for confirming there are proper arrangements in place to initiate, manage, monitor and finance a study. Sponsors must also ensure that appropriate indemnity is in place before research begins. 

The Co-ordinators for Non Commercial research Sponsored by NHSGGC are:

Click here for further information on NHS GG&C Sponsored Research, including details on the specific therapy areas covered by each Portfolio Team

Non Commercial NHSGGC Hosted

For all Non Commercial studies that aren’t Sponsored by NHSGGC, the Research Facilitators will be: 

Click here for further information on NHS GG&C Hosted Research, including details on the specific therapy areas covered by each Portfolio Team

Low Risk Non Commercial NHSGGC Sponsored and NHSGGC Hosted

The Proportionate Review (PR) Team deal with the approvals for all “low risk” studies.  We have deemed “low risk” studies to be all Study Types from the IRAS Form that are: 

  1. Study administering questionnaires/interviews for quantitative analysis, or using mixed quantitative/qualitative methodology
  2. Study involving qualitative methods only
  3. Study limited to working with human tissue samples (or other biological samples) and data (specific project only)
  4. Study limited to working with data (specific project only)
  5. Research tissue bank or Research database
  6. Patient Information Centres (PIC)
  7. Basic Science Study involving procedures with human participants

 Commercial therapy areas 

Portfolio 1

  • Haematology (Oncology only)
  • Medical Genetics
  • Oncology
  • Pathology

Network: Cancer

Co-ordinator: Dr George Bakirtzis

Portfolio 2

  • Cardiology
  • Cardiovascular & Exercise Medicine
  • Diabetes
  • Gastroenterology
  • Haematology (Non Oncology)
  • Heath Services and Delivery Research (Includes Biochemistry, Immunology, Clinical and Medical Physics, Radiology, Nuclear Medicine and Homeopathy)
  • Haepatology
  • Infectious Diseases (Includes Infectious Diseases, Microbiology, Virology and Bacteriology)
  • Metabolic and Endocrine (Includes Dietetics, Metabolic Disease and Human Nutrition)
  • Orthopaedics
  • Public Health (Includes Occupational Health, Sexual Health and Family Planning)
  • Physiotherapy
  • Renal and Urology
  • Rheumatology
  • Respiratory Medicine
  • Surgery (Includes Burns, Plastic Surgery, Cardiothoracic Surgery and Vascular Surgery)

Networks: CardiovascularDiabetesInfectious DiseasesStrokeMusculoskeletal Health;

Co-ordinator: Mr Ross Nicol

Portfolio 3

  • A&E, Injuries and Emergencies
  • Anaesthetics
  • Critical Care
  • Dermatology
  • Ear, Nose and Throat (ENT)
  • Mental Health (Includes Adolescent Psychiatry, Alcohol/Drugs Misuse, Adult Mental Health, Psychological Medicine/ Clinical Psychology, Family Psychiatry, Forensic Psychiatry and Learning Disability)
  • Neurology (Non Stroke) (Includes Parkinson’s Disease, Multiple Sclerosis, Epilepsy, Migraine & Headache)
  • Paediatrics
  • Obstetrics, Gynaecology and Midwifery
  • Ophthalmology
  • Oral and Dental Health (Includes Oral Medicine, Dentistry/Community Dentistry and Dentistry – Restorative)
  • Stroke

Networks: DEnDRONMental HealthChildren’s Research Network 

Co-ordinator: Mrs Ruth Pink

Non commercial NHSGCC sponsored therapy areas
  • Critical Care
  • Dermatology
  • Ear, Nose and Throat (ENT)
  • Medical Genetics 
  • Mental Health (Includes Adolescent Psychiatry, Alcohol/Drugs Misuse, Adult Mental Health, Psychological Medicine/ Clinical Psychology, Family Psychiatry, Forensic Psychiatry and Learning Disability)
  • Neurology (Non Stroke) (Includes Dementia, Parkinson’s Disease, Multiple Sclerosis, Epilepsy, Migraine & Headache)
  • Ophthalmology
  • Pathology
  • Stroke

Networks: StrokeDEnDRON;Mental Health;ENT;

Sponsor Co-ordinator: Mrs Barbara Ross

  • Anaesthetics
  • Cardiology (Colin Berry and John McMurray team led)
  • Cardiovascular & Exercise Medicine
  • Diabetes
  • Heath Services and Delivery Research (Includes Biochemistry, Immunology, Clinical and Medical Physics, Radiology, Nuclear Medicine and Homeopathy)
  • Haepatology
  • Infectious Diseases (Includes Infectious Diseases, Microbiology, Virology and Bacteriology)
  • Metabolic and Endocrine (Includes Dietetics, Metabolic Disease and Human Nutrition)
  • Physiotherapy
  • Public Health (Includes Occupational Health, Sexual Health, Reproductive Health and Family Planning)
  • Surgery (Includes Burns, Plastic Surgery, Cardiothoracic Surgery and Vascular Surgery)

Networks: CardiovascularDiabetesInfectious Diseases;

Sponsor Co-ordinator: Dr Maureen Travers

  • Paediatrics and Neonatal
  • Gastroenterology
  • Orthopaedics
  • Rheumatology
  • A & E, Trauma and Emergencies
  • Haematology (Non Oncology and Oncology)
  • Oral and Dental Health* (Includes Oral Medicine, Dentistry/Community Dentistry, Restorative Dentistry and Paediatric Dentistry)
  • Cardiology (John Cleland team led)
  • Obstetrics, Gynaecology and Midwifery
  • Renal and Urology
  • Respiratory Medicine

Networks / Speciality Group: Children’s Research NetworkDental; NRS Oral & Dental Specialty Group; NRS Non- Malignant Haematology; NRS Trauma and Emergencies; Musculoskeletal Health; NRS Renal Speciality Group; Cardiovascular;

Sponsor Co-ordinator: Dr Pamela Sandu

  • Oncology

Networks: Cancer;

Sponsor Co-ordinator: Ms Joanne McGarry (for ALL Oncology and CRUK co-ordinated Oncology studies)

Based on disease area for:

  • Palliative Care

PR Portfolio

The Proportionate Review (PR) Team deal with the approvals for all “low risk” studies.  We have deemed “low risk” studies to be all Study Types from the IRAS Form that are: 

  1. Study administering questionnaires/interviews for quantitative analysis, or using mixed quantitative/qualitative methodology
  2. Study involving qualitative methods only
  3. Study limited to working with human tissue samples (or other biological samples) and data (specific project only)
  4. Study limited to working with data (specific project only)
  5. Research tissue bank or Research database
  6. Patient Information Centres (PIC)
  7. Basic Science Study involving procedures with human participants

Networks: 

Research Facilitator: Ms Rebecca Jardine

Non commercial NHSGGC hosted therapy areas

Portfolio 1

  • A & E, Injuries and Emergencies
  • Critical Care
  • Ear, Nose and Throat (ENT)
  • Haematology (Oncology only)
  • Medical Genetics
  • Mental Health (Includes Adolescent Psychiatry, Alcohol/Drugs Misuse, Adult Mental Health, Psychological Medicine/ Clinical Psychology, Family Psychiatry, Forensic Psychiatry and Learning Disability)
  • Neurology (Non Stroke) (Includes Dementia, Parkinson’s Disease, Multiple Sclerosis, Epilepsy, Migraine & Headache)
  • Obstetrics, Gynaecology and Midwifery
  • Oncology
  • Ophthalmology
  • Oral and Dental Health (Includes Oral Medicine, Dentistry/Community Dentistry and Dentistry – Restorative)
  • Pathology

Network: Cancer; DEnDRON;Mental Health;Children’s Research Network

Research Facilitator: Dr Ross Collins 

Portfolio 2

  • Anaesthetics
  • Cardiology
  • Cardiovascular & Exercise Medicine
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Haematology (Non Oncology)
  • Heath Services and Delivery Research (Includes Biochemistry, Immunology, Clinical and Medical Physics, Radiology, Nuclear Medicine and Homeopathy)
  • Haepatology
  • Infectious Diseases Includes Infectious Diseases, Microbiology, Virology and Bacteriology)
  • Metabolic and Endocrine) (Includes Dietetics, Metabolic Disease and Human Nutrition)
  • Orthopaedics
  • Public Health (Includes Occupational Health, Sexual Health, Reproductive Health and Family Planning)
  • Physiotherapy
  • Renal and Urology
  • Rheumatology
  • Respiratory Medicine
  • Stroke
  • Surgery (Includes Burns, Plastic Surgery, Cardiothoracic Surgery and Vascular Surgery)

Networks: CardiovascularDiabetesInfectious DiseasesStrokeChildren’s Research NetworkMusculoskeletal Health

Research Facilitator: Mrs Karen Puglisevich Chase